HOME >> BIOLOGY >> NEWS
Anti cancer virotherapy well tolerated in first human administration, research finds

(Banff, Canada March 14, 2005) An international medical conference here heard that an Australian developed anti-cancer therapy based on the use of a common cold virus to control cancer cell growth has begun safety testing in human subjects.

The research was presented to the third International Meeting on Replicating Oncolytic Virus Therapeutics, on Friday 11 March by Newcastle University associate professor, Darren Shafren.

The technology is licensed to Australian Stock Exchange listed biotechnology company, Psiron Limited (ASX:PSX).

Professor Shafren has previously tested this virotherapy on cancer tumours in mice and this is the first testing in humans. Two patients only were approved to receive this virotherapy.

Professor Shafren reported to the conference that this research team had injected a single dose of Coxsackie A21 (CVA21) virus directly into the advanced melanoma tumours of these patients with end stage disease.

Both patients had many sites of spread melanoma tumours and injected and non-injected tumours were subsequently removed from the patients.

Professor Shafren's group observed no "systemic toxic effects or localised inflammation" as a result of the injections of the viral material and basic blood chemistry and liver enzyme levels remain unchanged in the these two patients.

Professor Shafren told conference delegates that these findings suggested that administration of a single dose of CVA21 directly into a cancerous tumour was well tolerated.

"Administration of CVA21 may be of potential therapeutic benefit in controlling the spread of melanoma," Professor Shafren said.

CVA21 is one of a small group of naturally occurring rather than genetically modified viruses the Shafren team has been investigating as potential therapies for different hard to treat malignancies including melanoma and ovarian cancer.

These viruses occur naturally and routinely in the community causing m
'"/>

Contact: David Sheon
dsheon@sciwords.com
202 518 6321
SciWords
14-Mar-2005


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Newly created cancer stem cells could aid breast cancer research
3. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
4. ESF EURYI award winner aims to stop cancer cells reading their own DNA
5. No evidence that widely prescribed statins protect against prostate cancer
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. New study suggests Concord grape juice may provide protection against breast cancer
8. New test improves detection of liver cancer
9. High-intensity ultrasound may launch attack on cancer, wherever it lurks
10. Unknotting DNA clue to cancer syndrome
11. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... ... January 07, 2019 , ... ... solutions, is proud to welcome Thomas Kennedy as head of sales and business ... for PureWay. , Mr. Kennedy has previously worked for Johnson & Johnson Medical, ...
(Date:1/4/2019)... ... January 02, 2019 , ... Lifecycle Biotechnologies ... the life science tools and service supplier turned 40 in 2018 and for ... catalog features not just part numbers like most catalogs, but rather, insightful information ...
(Date:12/25/2018)... ... 2018 , ... Researchers at the Icahn School of Medicine ... a long-standing computational concept known as “blacklisting,” which is commonly employed as a ... as a filter to single out genetic variations in patient genomes and exomes ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of ... were named by a selection committee made up of industry leaders identified by the ... Development grants are mentored awards created to support ASGCT members designing transformative pilot studies ...
(Date:1/4/2019)... (PRWEB) , ... January 01, 2019 , ... ... first Microbiome Conference at the World Economic Forum Annual Meeting January 22-25, 2019 ... conference is invitation-only. , The World Economic Forum Annual Meeting brings together leaders ...
(Date:12/20/2018)... ... ... New Year’s brings reflection and desire to improve for individuals and businesses ... on the horizon, Jim Kasic, president and CEO of Boulder iQ, suggests five resolutions ... Regulation (MDR), digital health, and big data are just a few of the challenges ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT , ... biosciences ventures invited to participate in the annual program. Twelve ventures will participate ... and a professional network. All startups receive an entrepreneur coach, access to active ...
Breaking Biology Technology:
Cached News: